The AACR Team Science Award was established by the American Association for Cancer Research and Eli Lilly and Company to acknowledge and catalyze the growing importance of interdisciplinary teams to the understanding of cancer and/or the translation of research discoveries into clinical cancer applications.
This Award recognizes an outstanding interdisciplinary research team for their innovative and meritorious science that has advanced or may advance our fundamental knowledge of cancer, or a team that has applied existing knowledge to advancing the detection, diagnosis, prevention, or treatment of cancer.
Deadline for nominations: Sep. 15, 2023
Cancer researchers affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science anywhere in the world may be nominated. Such institutions include those in academia, industry, or government.
Institutions and/or organizations are not eligible to receive the Award.
Eligible teams may be comprised of independent faculty-level researchers providing complementary interdisciplinary expertise, each of whom have made separate substantive and quantifiable contributions to the research being recognized.
Team members may be working within the same institution or at several institutions. However, if researchers are employed at the same institution, they must possess separate funding and research space.
The team research being recognized should reflect work focused on a specific scientific goal that otherwise would not be realized by any single component of the team.
Teams comprising academic and industry researchers will be accepted.
